We are live on ! Find out more
FFA

Fairfield Financial Advisors Portfolio holdings

AUM $290M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+15.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$284M
AUM Growth
-$9.82M
Cap. Flow
-$2.05M
Cap. Flow %
-0.72%
Top 10 Hldgs %
60.98%
Holding
302
New
12
Increased
79
Reduced
72
Closed
39

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$1.1M
2
ISRG icon
Intuitive Surgical
ISRG
+$857K
3
COST icon
Costco
COST
+$849K
4
GE icon
GE Aerospace
GE
+$832K
5
CAT icon
Caterpillar
CAT
+$528K

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$894K
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$790K
3
ABT icon
Abbott
ABT
+$768K
4
DE icon
Deere & Co
DE
+$724K
5
MRK icon
Merck
MRK
+$572K

Sector Composition

Rank Sector Weight
1 Technology 12.88%
2 Healthcare 9.35%
3 Financials 7.26%
4 Consumer Discretionary 4.48%
5 Communication Services 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVAV icon
176
AeroVironment
AVAV
$9.45B
$3.85K ﹤0.01%
+25
New +$4.89K
ALGN icon
177
Align Technology
ALGN
$12.3B
$3.75K ﹤0.01%
18
– –
KHC icon
178
Kraft Heinz
KHC
$30B
$3.7K ﹤0.01%
120
+1
+0.8% +$33
LDOS icon
179
Leidos
LDOS
$17.3B
$3.61K ﹤0.01%
+25
New +$4.16K
ABNB icon
180
Airbnb
ABNB
$106B
$3.55K ﹤0.01%
27
– –
DOW icon
181
Dow Inc
DOW
$21.2B
$2.61K ﹤0.01%
65
– –
KD icon
182
Kyndryl
KD
$3.05B
$1.97K ﹤0.01%
57
– –
CLF icon
183
Cleveland-Cliffs
CLF
$6.99B
$1.88K ﹤0.01%
200
– –
KVUE icon
184
Kenvue
KVUE
$36.9B
$1.71K ﹤0.01%
80
-553
-87% -$12.5K
BMY icon
185
Bristol-Myers Squibb
BMY
$132B
$1.7K ﹤0.01%
30
– –
GPCR icon
186
Structure Therapeutics
GPCR
$3.78B
$1.6K ﹤0.01%
59
– –
MMM icon
187
3M
MMM
$94.3B
$1.29K ﹤0.01%
10
– –
VKTX icon
188
Viking Therapeutics
VKTX
$4B
$1.29K ﹤0.01%
32
– –
JYNT icon
189
The Joint Corp
JYNT
$119M
$1.06K ﹤0.01%
100
– –
ACCO icon
190
Acco Brands
ACCO
$407M
$1.05K ﹤0.01%
200
– –
LQMT
191
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
$850 ﹤0.01%
20,000
– –
UAA icon
192
Under Armour
UAA
$2.6B
$828 ﹤0.01%
100
– –
WBD icon
193
Warner Bros
WBD
$67.1B
$465 ﹤0.01%
44
– –
IHAK icon
194
iShares Cybersecurity and Tech ETF
IHAK
$1.1B
$440 ﹤0.01%
9
– –
MRNA icon
195
Moderna
MRNA
$23.6B
$416 ﹤0.01%
10
– –
TSM icon
196
TSMC
TSM
$2.18T
$395 ﹤0.01%
+2
New +$387
PHM icon
197
Pultegroup
PHM
$25.3B
$210 ﹤0.01%
2
– –
CRNC icon
198
Cerence
CRNC
$413M
$196 ﹤0.01%
25
– –
IYJ icon
199
iShares US Industrials ETF
IYJ
$2.02B
$134 ﹤0.01%
+1
New +$138
SOLV icon
200
Solventum
SOLV
$14.1B
$132 ﹤0.01%
2
– –
5 6 7
8
9

Similar funds

SI
Saxon Interests Houston, Texas $290M AUM 19.97% 1-Year Est. Return
OCM
Orion Capital Management Coronado, California $290M AUM 17.97% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
EPIME
Evelyn Partners Investment Management (Europe) Dublin $291M AUM 20.34% 1-Year Est. Return
DP
Denver PWM Denver, Colorado $291M AUM 12.15% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PIA
PineBridge Investments Asia Hong Kong $289M AUM
GIM
Goodlander Investment Management Dallas, Texas $289M AUM 225.62% 1-Year Est. Return

Fairfield Financial Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Fairfield Financial Advisors held 302 positions worth $284M, down 3.3% from $294M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Fairfield Financial Advisors's Q4 2024 filing shows 12 new, 79 increased, 72 reduced and 39 closed positions. Its largest new stake was Service Corp International: 2,390 shares worth $191K. The largest sale was Novo Nordisk, an estimated $894K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Fairfield Financial Advisors's largest Q4 2024 buy was Service Corp International: 2,390 shares worth $191K.
  • Fairfield Financial Advisors added most to Walmart Inc in Q4 2024, an estimated $1.1M increase.
  • Fairfield Financial Advisors's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $894K.
  • Fairfield Financial Advisors fully exited Hershey in Q4 2024, selling an estimated $74.1K.
  • Fairfield Financial Advisors's ten largest holdings make up 61% of its $284M portfolio in Q4 2024.
  • Fairfield Financial Advisors opened 12 new positions and closed 39 in Q4 2024.
  • Fairfield Financial Advisors's portfolio value fell 3.3% quarter-over-quarter to $284M.

Based on Fairfield Financial Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.